| RS1194633608 |
ILDR1
|
Health Risk |
Pathogenic |
— |
| RS119463988 |
PDSS1
|
Health Risk |
Pathogenic |
Deafness-encephaloneuropathy-obesity-valvulopathy syndrome, Deafness-encephaloneuropathy-obesity-valvulopathy syndrome |
| RS119463989 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS119463990 |
FKTN
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS119463991 |
FKTN
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS119463992 |
FKTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Walker-Warburg congenital muscular dystrophy |
| RS119463993 |
FKTN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS119463994 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1X, Walker-Warburg congenital muscular dystrophy |
| RS119463995 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS119463996 |
FKTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS119464997 |
FKTN
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS119464998 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS119465999 |
UTP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary North American Indian childhood cirrhosis, UTP4-related disorder |
| RS119466000 |
LRPPRC
|
Health Risk |
Pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS119466001 |
BBS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome |
| RS119466002 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 1/7, digenic |
| RS119467003 |
TDP1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS1194673433 |
ERCC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum group B, Xeroderma pigmentosum group B |
| RS1194679272 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, PCCA-related disorder |
| RS119468004 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia due to ubiquinone deficiency, See cases |
| RS119468005 |
COQ8A
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS119468006 |
COQ8A
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS119468008 |
COQ8A
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS119468010 |
MPO
|
Health Risk |
Pathogenic/Likely pathogenic |
Myeloperoxidase deficiency, Alzheimer disease type 1 |
| RS119469012 |
MPO
|
Health Risk |
Pathogenic |
Myeloperoxidase deficiency, Myeloperoxidase deficiency |
| RS119469013 |
MPO
|
Health Risk |
Pathogenic |
Myeloperoxidase deficiency, Myeloperoxidase deficiency |
| RS119469014 |
MPO
|
Health Risk |
Pathogenic/Likely pathogenic |
Myeloperoxidase deficiency, MPO-related disorder |
| RS1194694298 |
PPM1D
|
Health Risk |
Likely pathogenic |
— |
| RS119470016 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS119470017 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS119470018 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS119470019 |
GFM1
|
Health Risk |
Pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS119470020 |
GFM1
|
Health Risk |
Pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1194700242 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1194707294 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS119471021 |
HPS4
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS119471022 |
HPS4
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS119471023 |
HPS4
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome |
| RS119471024 |
HPS4
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS119471025 |
HPS4
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS119472026 |
DUOX2
|
Health Risk |
Pathogenic |
Thyroid dyshormonogenesis 6, Inborn genetic diseases |
| RS119472027 |
DUOX2
|
Health Risk |
Pathogenic |
Thyroid dyshormonogenesis 6, Familial thyroid dyshormonogenesis |
| RS119472028 |
DUOX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Thyroid dyshormonogenesis 6, Familial thyroid dyshormonogenesis |
| RS119472029 |
DUOX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Thyroid dyshormonogenesis 6, DUOX2-related disorder |
| RS119473030 |
SLC25A19
|
Health Risk |
Pathogenic |
Amish lethal microcephaly, Amish lethal microcephaly |
| RS119473031 |
MLPH
|
Health Risk |
Likely pathogenic |
Griscelli syndrome type 3, Griscelli syndrome type 3 |
| RS119473032 |
LZTS1
|
Health Risk |
Pathogenic |
Esophageal squamous cell carcinoma, somatic |
| RS119473033 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, 9 conditions |
| RS119473034 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS119473035 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS119473036 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS119473037 |
SMARCAL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS119473038 |
SMARCAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schimke immuno-osseous dysplasia, Nephrotic syndrome |
| RS119474039 |
EIF2B3
|
Health Risk |
Pathogenic/Likely pathogenic |
Vanishing white matter disease, Leukoencephalopathy with vanishing white matter 3 |
| RS119475040 |
ANTXR1
|
Health Risk |
risk factor |
Capillary infantile hemangioma, Capillary infantile hemangioma |
| RS119475041 |
DHCR24
|
Health Risk |
Likely pathogenic |
Desmosterolosis, Desmosterolosis |
| RS119475042 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS119475043 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS119476044 |
EGLN1
|
Health Risk |
Pathogenic |
Erythrocytosis, familial |
| RS119476045 |
EGLN1
|
Health Risk |
Pathogenic |
Erythrocytosis, familial |
| RS119476046 |
ATL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 3A, Neuropathy |
| RS119476047 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS119476048 |
ATL1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS119476049 |
ATL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS119476050 |
ATL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 3A, Inborn genetic diseases |
| RS119476051 |
ATL1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1194763374 |
RMND1
|
Health Risk |
Pathogenic |
— |
| RS1194768011 |
PTEN
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS119477052 |
VPS13A
|
Health Risk |
Pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS119477053 |
VPS13A
|
Health Risk |
Pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS119477055 |
UBR1
|
Health Risk |
Pathogenic |
Johanson-Blizzard syndrome, Johanson-Blizzard syndrome |
| RS119477056 |
CD96
|
Health Risk |
Pathogenic |
C syndrome, C syndrome |
| RS1194776238 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 2, von Willebrand disease type 1 |
| RS119478058 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome type 2, Imerslund-Grasbeck syndrome |
| RS119478059 |
MRPS22
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia with lactic acidemia and hyperammonemia, Ovarian dysgenesis 7 |
| RS119479061 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS119479062 |
PCNT
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS119479063 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS119479064 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS119479065 |
ABCG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Sitosterolemia 2, Sitosterolemia |
| RS119479066 |
ABCG5
|
Health Risk |
Pathogenic |
Sitosterolemia 2, ABCG5-related disorder |
| RS119479067 |
ABCG5
|
Health Risk |
Pathogenic |
Sitosterolemia 2, Sitosterolemia |
| RS1194793421 |
MSH2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome |
| RS119480069 |
ABCG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Sitosterolemia 2, Sitosterolemia |
| RS119480070 |
ABCG5
|
Health Risk |
Pathogenic |
Sitosterolemia 2, Sitosterolemia 2 |
| RS119480071 |
LPIN1
|
Health Risk |
Pathogenic |
Myoglobinuria, acute recurrent |
| RS119480072 |
LPIN1
|
Health Risk |
Pathogenic |
Myoglobinuria, acute recurrent |
| RS119480073 |
LPIN1
|
Health Risk |
Pathogenic |
Myoglobinuria, acute recurrent |
| RS119481074 |
HSD17B3
|
Health Risk |
Likely pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Testosterone 17-beta-dehydrogenase deficiency |
| RS119481075 |
HSD17B3
|
Health Risk |
Pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Pseudohermaphroditism |
| RS119481076 |
HSD17B3
|
Health Risk |
Pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Pseudohermaphroditism |
| RS119481077 |
HSD17B3
|
Health Risk |
Pathogenic/Likely pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Pseudohermaphroditism |
| RS119481078 |
HSD17B3
|
Health Risk |
Likely pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Testosterone 17-beta-dehydrogenase deficiency |
| RS119481079 |
HSD17B3
|
Health Risk |
Pathogenic/Likely pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Testosterone 17-beta-dehydrogenase deficiency |
| RS119481080 |
HSD17B3
|
Health Risk |
Pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Testosterone 17-beta-dehydrogenase deficiency |
| RS119482081 |
SPTLC1
|
Health Risk |
Likely pathogenic |
Hereditary sensory and autonomic neuropathy type 1, Neuropathy |
| RS119482082 |
SPTLC1
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 1, Charcot-Marie-Tooth disease |
| RS119482083 |
SPTLC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary sensory and autonomic neuropathy type 1, Charcot-Marie-Tooth disease |
| RS119483085 |
NDRG1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4D, Charcot-Marie-Tooth disease type 4 |
| RS119484086 |
ELAC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Prostate cancer, hereditary |